Johnson & Johnson said the Food and Drug Administration approved its treatment of locally-advanced or metastatic non-small cell lung cancer for adults. The treatment, called Rybrevant, has been ...
The 1995 cuts helped lay the groundwork for a soft landing and the late '90s boom years. Party leaders are discussing a three-month deal that is expected to be amenable to Democrats. Sales of ...